<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02707783</url>
  </required_header>
  <id_info>
    <org_study_id>FEAST.RU</org_study_id>
    <nct_id>NCT02707783</nct_id>
  </id_info>
  <brief_title>Feasibility and Outcomes of Complete Coronary Revascularization Using BVS in All-comer Patients With Angina</brief_title>
  <acronym>FEASTRU</acronym>
  <official_title>Feasibility and Outcomes of Complete Coronary Revascularization Using Bioresorbable Vascular Scaffold in All-comer Patients With Stable and Unstable Angina: A Multi-centre Registry in Russian Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>International Foundation for Development of Medical Science and Education Healthy Heart</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>KCRI</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>International Foundation for Development of Medical Science and Education Healthy Heart</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is feasibility of complete coronary revascularization with bioresorbable
      vascular scaffold (BVS) implantation and assessment of treatment outcomes in a group of
      consecutive patients with stable and unstable angina in Russian population.

      The hypothesis of this registry study: 1) Complete coronary revascularization with BVS
      implantation will be feasible to perform in at least 70 percent of patient population with
      stable and unstable angina qualified for revascularization after coronary angiography, 2)
      Complete revascularization with BVS is as safe and effective as revascularization with
      standard BMS (Bare Metal Stent BMS/ Drug Eluting Stent DES stent implantation (published
      literature comparators in matched populations).

      Up to 2500 patients will be enrolled in 13 Russian high volume invasive cardiology centres.
      12 month clinical observation and 5-year clinical follow-up is expected.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study design: Data regarding all consecutive patients qualified for revascularization (PCI
      Percutaneous Coronary Intervention or CABG Coronary Artery Bypass Grafting) will be collected
      in this prospective study. Information regarding revascularization strategy will be collected
      as detailed information concerning PCI procedure. In case of PCI with other than BVS stent
      implantation (BMS or/and metallic DES) information collected in the study will contain at
      least:

        -  Reason why BVS was not implanted

        -  Final result of baseline treatment

        -  Acute and long-term outcome of treatment (12 month clinical observation); NB. 5-year
           clinical follow-up is also expected.

      The enrollment phase of the registry is not expected to last longer than 12 months.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2015</start_date>
  <completion_date type="Anticipated">August 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Angiographic endpoints: assessment of stent implantation final result:stent delivery, technical success (yes/no)</measure>
    <time_frame>periprocedural</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Angiographic endpoints: assessment of stent implantation final result: percentage of residual stenosis (%)</measure>
    <time_frame>periprocedural</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Angiographic endpoints: assessment of stent implantation final result: dissection (yes/no)</measure>
    <time_frame>periprocedural</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Angiographic endpoints: assessment of stent implantation final result: slow-flow (yes/no)</measure>
    <time_frame>periprocedural</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Angiographic endpoints: assessment of stent implantation final result: no-flow (yes/no)</measure>
    <time_frame>periprocedural</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Angiographic endpoints: assessment of stent implantation final result: distal embolization (yes/no)</measure>
    <time_frame>periprocedural</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Angiographic endpoints: assessment of stent implantation final result: side-branch occlusion (yes/no)</measure>
    <time_frame>periprocedural</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Angiographic endpoints: assessment of stent implantation final result: coronary artery perforation (yes/no)</measure>
    <time_frame>periprocedural</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Acute gain (mm)</measure>
    <time_frame>periprocedural</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Major Adverse Cardiovascular Events</measure>
    <time_frame>From hospital discharge till 12 months follow up</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Major Adverse Cardiovascular Events</measure>
    <time_frame>in 12 month follow up</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>TVF (Target Vessel Failure)</measure>
    <time_frame>in 12 month follow-up</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Any revascularization</measure>
    <time_frame>in 12 month follow-up</time_frame>
    <description>Numbers of any revascularization per patient.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stent thrombosis (possible and probable)</measure>
    <time_frame>in 12 month follow-up</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Periprocedural MI (Myocardial Infarction) (yes/no)</measure>
    <time_frame>periprocedural</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Angina assessment questionnaire</measure>
    <time_frame>12 month follow-up</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">2500</enrollment>
  <condition>Angina</condition>
  <arm_group>
    <arm_group_label>Bioresorbable vascular scaffold (BVS) implantation</arm_group_label>
    <description>Patients with un/stable angina that require coronary revascularization undergoing the BVS implantation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Bioresorbable vascular scaffold (BVS) implantation</intervention_name>
    <arm_group_label>Bioresorbable vascular scaffold (BVS) implantation</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with stable and unstable angina qualified for revascularization (PCI or CABG)
        after coronary angiography.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patient characteristics

          -  Age &gt; 18 years

          -  Able and willing to give informed consent

          -  Willing to comply with specified follow-up evaluations

          -  Clinical manifestation of coronary artery disease: stable angina or unstable angina

          -  Indications for coronary revascularization

        Exclusion Criteria:

        Patient characteristics

          -  Acute Myocardial infarction

          -  Cardiogenic shock

          -  Any reason for patient's inability to comply with 12-month double antiplatelet therapy
             (DAPT)

          -  Absolute contraindications to DES or BVS implantation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Piotr Musiałek, MD DPhil</last_name>
    <role>Study Chair</role>
    <affiliation>John Paul II Hospital in Krakow, Poland</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Piotr Musiałek, MD DPhil</last_name>
    <phone>00 48 12 614 22 87</phone>
    <email>pmusialek@szpitaljp2.krakow.pl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Zbigniew Siudak, MD DPhil</last_name>
    <phone>00 48 12 623 19 30</phone>
    <email>zbigniew.siudak@kcri.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Federal Center for Cardiovascular Surgery</name>
      <address>
        <city>Chelyabinsk</city>
        <state>Av. Hero of Russia 2 Rodionov E.N.</state>
        <zip>454003</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vasily Masasin, Dr</last_name>
    </contact>
    <contact_backup>
      <last_name>Alexsander Kuzmenko, Dr</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Federal Cardiovascular Center</name>
      <address>
        <city>Krasnoyarsk</city>
        <state>Karaulnaya 45</state>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dmitry Stolyarov, Dr</last_name>
    </contact>
    <contact_backup>
      <last_name>Elena Korobitcina</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Regional Hospital</name>
      <address>
        <city>Magadan</city>
        <state>Nagaevskaya 40</state>
        <zip>685 000</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vitaliy Loenko, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Regional Clinical Hospital n.a. S.V.</name>
      <address>
        <city>Krasnodar</city>
        <state>Ochapovskogo</state>
        <zip>350 086</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexey Fedorchenko, Dr</last_name>
    </contact>
    <contact_backup>
      <last_name>Oganes Oganeysan</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Federal Cardiovascular Center</name>
      <address>
        <city>Kaliningrad</city>
        <zip>238 312</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tigran Akobyan, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Federal State Budgetary Scientific Institution Research Institute for Complex Issues of Cardiovascular Diseases</name>
      <address>
        <city>Kemerovo</city>
        <zip>650002</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vkadimir Ganyukov, Prof</last_name>
    </contact>
    <contact_backup>
      <last_name>Nikita Kochergin, Dr</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Regional Clinical Hospital</name>
      <address>
        <city>Krasnoyarsk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexey Protopopov</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinical Hospital No 1 of Department of Presidents Affairs</name>
      <address>
        <city>Moscow</city>
        <zip>121352</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Narek Zakaryan, Dr</last_name>
    </contact>
    <contact_backup>
      <last_name>Alexey Pankov, Dr</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>President's Hospital with Policlinic</name>
      <address>
        <city>Moscow</city>
        <zip>121359</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Central Railway Hospital 2</name>
      <address>
        <city>Moscow</city>
        <zip>129128</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zaur Shugushev, Dr</last_name>
    </contact>
    <contact_backup>
      <last_name>Ekaterina Gitelzon, Dr</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>CELT Hospital</name>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Avtandil Babunashvili, Prof</last_name>
    </contact>
    <contact_backup>
      <last_name>Dmitry Kartashov, Dr</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>City Clinical Hospital named S.S.Yudina Department of Health of the City of Moscow</name>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anton Koledinsky, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Federal Cardiovascular Center</name>
      <address>
        <city>Perm</city>
        <zip>614 013</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vitaliy Likhachev, Dr</last_name>
    </contact>
    <contact_backup>
      <last_name>Alexey Rodionov, Dr</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Tyumen Cardiology Center</name>
      <address>
        <city>Tyumen</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vadim Kuznetsov, Prof</last_name>
    </contact>
    <contact_backup>
      <last_name>Ivan Bessonov, Dr</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 18, 2016</study_first_submitted>
  <study_first_submitted_qc>March 11, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 14, 2016</study_first_posted>
  <last_update_submitted>March 20, 2017</last_update_submitted>
  <last_update_submitted_qc>March 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>stable and unstable angina</keyword>
  <keyword>bioresorbable vascular scaffold</keyword>
  <keyword>BVS</keyword>
  <keyword>PCI</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Angina Pectoris</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

